▶ 調査レポート

世界のin vitro毒性試験市場2022年-2032年:方法別(細胞アッセイ-生細胞、固定細胞生化学アッセイ、In-Silico、Ex-vivo)、技術別(細胞培養技術、ハイスループット技術、分子イメージング技術、オミックス技術)エンドユーザー別、用途別

• 英文タイトル:In-vitro Toxicology Testing Market by Method (Cellular Assay- Live Cells, Fixed Cells Biochemical Assay, In-Silico, and Ex-vivo), by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology), by End-use, by Application and by Region - 2022 to 2032

Transparency Market Researchが調査・発行した産業分析レポートです。世界のin vitro毒性試験市場2022年-2032年:方法別(細胞アッセイ-生細胞、固定細胞生化学アッセイ、In-Silico、Ex-vivo)、技術別(細胞培養技術、ハイスループット技術、分子イメージング技術、オミックス技術)エンドユーザー別、用途別 / In-vitro Toxicology Testing Market by Method (Cellular Assay- Live Cells, Fixed Cells Biochemical Assay, In-Silico, and Ex-vivo), by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology), by End-use, by Application and by Region - 2022 to 2032 / TMRGL73510資料のイメージです。• レポートコード:TMRGL73510
• 出版社/出版日:Transparency Market Research / 2022年11月16日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥869,250 (USD5,795)▷ お問い合わせ
  Multi User¥1,319,250 (USD8,795)▷ お問い合わせ
  Corporate License¥1,769,250 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当レポートは英文です。下記の日本語概要・目次は自動翻訳を利用し作成されました。正確な概要・目次はお問い合わせフォームからサンプルを請求してご確認ください。

2017年から2021年までのin vitro毒性試験市場の収益と2022年から2032年までの需要見通しとの比較

市場調査および競合情報提供会社であるTransparency Market Research社のin vitro毒性試験市場調査によりますと、歴史的に2017年から2021年まで、市場価値は約11.3%のCAGRで増加し、世界市場において北米が大きなシェアを占めているとのことです。
体外毒性試験を通じて発見された早期の有害事象は、創薬プロジェクトの大部分を通じて重篤な有害事象を防ぐのに役立つため、数十種類の医薬品の開発が体外毒性試験の市場を牽引すると予測されます。2020年11月以降、コロナウイルスに関連する医薬品は590品目開発されています。多くの医薬品開発の取り組みが、体外毒性試験サービスの需要を高めると予想されます。その結果、in vitro毒性試験市場は今後10年間で13%のCAGRで成長すると予想されます。

in vitro毒性試験市場の成長見通しは?

医薬品の安全性を評価するためのin vitro毒性試験における大幅な改善や、細胞や組織に対する医薬品の潜在的な影響の評価は、市場の収益創出を後押しすると予想されます。このようなアッセイに対するニーズの増加に伴い、企業はin vitro毒性試験の需要に応えるため、提供範囲を広げてきました。また、バイオテクノロジーやバイオインフォマティクス部門が、動物モデルでインシリコシミュレーションを行うためのさまざまなツールを提供していることも、事業の成長に影響を与えています。さらに、さまざまな化学物質のインシリコ研究のための毒物学データベースの成長は、インビトロ手順の需要を促進し、結果として業界の伝播につながると予想されます。
研究に対する政府の重要な支援は、特定の償還規則と相まって、実験室分析や生体外検査のための自動化され技術的に洗練された機器を開発することにより、市場の安定性を向上させることを意図しています。逆に、現在の体外試験における免疫試験や免疫刺激の欠如は、業界の拡大を阻害する可能性が高いです。

地域別分析

in vitro毒性試験市場で最大のビジネスチャンスを提供すると予測される地域はどこですか?

北米は、2032年までに360億米ドル以上の市場が予測され、in vitro毒性試験市場の収益に大きく寄与しています。同地域の市場は、2022年から2032年の間に11%を超えるCAGRで成長すると予測されています。
米国では、バイオ医薬品メーカーによる生物製剤やバイオシミラー医薬品の導入が進んでおり、北米におけるin vitro毒性試験需要を後押ししています。さらに、政府当局が創薬投資や資金提供プロジェクトに参加しています。米国で創薬の基礎研究への投資や毒性試験の代替手法の利用改善に積極的に取り組んでいる団体には、国立衛生研究所や国防高等研究計画局などがあります。

カテゴリー別インサイト

細胞アッセイがin vitro毒性試験市場で大きな需要を獲得している理由は?

細胞毒性およびその他の生物化学物質を検出するための創薬スクリーニングの高まりにより、2021年には要求仕様に準拠したセルラーアッセイセグメントが市場を支配しました。大麻ベースの医薬品を検査するための新製品が登場し、業界の拡大を早めています。セルラーアッセイによる市場は、予測期間を通じてCAGR15.2%で拡大する見込みです。
薬物開発の初期段階において、多数の製薬およびバイオテクノロジー企業は、毒性スクリーニングのために細胞検査に大きく依存しています。In-vitro 細胞生存率テストは、低コスト、迅速な結果、自動化の機会など、さまざまな利点を提供します。しかし、これらの試験法には大きな技術的問題があり、動物実験に完全に取って代わるには至っていないため、その拡大には課題があります。一方、生体外培養の分野は、予測期間中、急速なペースで増加すると予測されます。
生体外または微小な摘出培養により、組織の自然な構造を維持しながら、無菌で規制された動的な環境で薬物スクリーニング試験を実施することができます。生体外モデルでは、生体外で検査や検出を行うことができるため、大きな利点があります。

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage

2.2. Market Definition

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on In-vitro Toxicology Testing Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

4. Market Background

4.1. In-vitro Toxicology Testing Market, by Key Countries

4.2. In-vitro Toxicology Testing Market Opportunity Assessment (US$ Mn)

4.2.1. Total Available Market

4.2.2. Serviceable Addressable Market

4.2.3. Serviceable Obtainable Market

4.3. Market Scenario Forecast

4.3.1. Demand in optimistic Scenario

4.3.2. Demand in Likely Scenario

4.3.3. Demand in Conservative Scenario

4.4. Investment Feasibility Analysis

4.4.1. Investment in Established Markets

4.4.1.1. In Short Term

4.4.1.2. In Long Term

4.4.2. Investment in Emerging Markets

4.4.2.1. In Short Term

4.4.2.2. In Long Term

4.5. Forecast Factors – Relevance & Impact

4.5.1. Top Companies Historical Growth

4.5.2. Growth in Automation, By Country

4.5.3. In-vitro Toxicology Testing Adoption Rate, By Country

4.6. Market Dynamics

4.6.1. Market Driving Factors and Impact Assessment

4.6.2. Prominent Market Challenges and Impact Assessment

4.6.3. In-vitro Toxicology Testing Market Opportunities

4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

5.2. Banking on with Segments High Incremental Opportunity

5.3. Peer Benchmarking

6. Global In-vitro Toxicology Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

6.1. Historical Market Analysis, 2017-2021

6.2. Current and Future Market Projections, 2022-2032

6.3. Y-o-Y Growth Trend Analysis

7. Global In-vitro Toxicology Testing Market Value Analysis 2017-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Method

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Method, 2017-2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method, 2022-2032

8.3.1. Cellular Assay

8.3.1.1. Live Cells

8.3.1.2. Fixed Cells

8.3.2. Biochemical Assay

8.3.3. In-Silico

8.3.4. Ex-vivo

8.4. Market Attractiveness Analysis By Method

9. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2017-2021

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032

9.3.1. Pharmaceutical Industry

9.3.2. Cosmetics & Household Products

9.3.3. Academic Institutes and Research Laboratories

9.3.4. Diagnostics

9.3.5. Chemical Industry

9.3.6. Food Industry

9.4. Market Attractiveness Analysis By End-use

10. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032

10.3.1. Cell Culture Technology

10.3.2. High Throughput Technology

10.3.3. Molecular Imaging

10.3.4. OMICS Technology

10.4. Market Attractiveness Analysis By Technology

11. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

11.3.1. Systemic Toxicology

11.3.2. Dermal Toxicity

11.3.3. Endocrine Disruption

11.3.4. Occular Toxicity

11.3.5. Other Applications

11.4. Market Attractiveness Analysis By Application

12. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. Asia Pacific

12.3.5. Middle East and Africa (MEA)

12.4. Market Attractiveness Analysis By Region

13. North America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

13.4.1. By Country

13.4.1.1. U.S.

13.4.1.2. Canada

13.4.1.3. Rest of North America

13.4.2. By Method

13.4.3. By End-use

13.4.4. By Application

13.4.5. By Technology

13.5. Market Attractiveness Analysis

13.5.1. By Country

13.5.2. By Method

13.5.3. By End-use

13.5.4. By Application

13.5.5. By Technology

14. Latin America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

14.4.1. By Country

14.4.1.1. Brazil

14.4.1.2. Mexico

14.4.1.3. Rest of Latin America

14.4.2. By Method

14.4.3. By End-use

14.4.4. By Application

14.4.5. By Technology

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Method

14.5.3. By End-use

14.5.4. By Application

14.5.5. By Technology

15. Europe In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

15.4.1. By Country

15.4.1.1. Germany

15.4.1.2. France

15.4.1.3. U.K.

15.4.1.4. Italy

15.4.1.5. Benelux

15.4.1.6. Nordic Countries

15.4.1.7. Rest of Europe

15.4.2. By Method

15.4.3. By End-use

15.4.4. By Application

15.4.5. By Technology

15.5. Market Attractiveness Analysis

15.5.1. By Country

15.5.2. By Method

15.5.3. By End-use

15.5.4. By Application

15.5.5. By Technology

16. Asia Pacific In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

16.4.1. By Country

16.4.1.1. China

16.4.1.2. Japan

16.4.1.3. South Korea

16.4.1.4. Rest of Asia Pacific

16.4.2. By Method

16.4.3. By End-use

16.4.4. By Application

16.4.5. By Technology

16.5. Market Attractiveness Analysis

16.5.1. By Country

16.5.2. By Method

16.5.3. By End-use

16.5.4. By Application

16.5.5. By Technology

17. Middle East and Africa In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

17.1. Introduction

17.2. Pricing Analysis

17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

17.4.1. By Country

17.4.1.1. GCC Countries

17.4.1.2. South Africa

17.4.1.3. Turkey

17.4.1.4. Rest of Middle East and Africa

17.4.2. By Method

17.4.3. By End-use

17.4.4. By Application

17.4.5. By Technology

17.5. Market Attractiveness Analysis

17.5.1. By Country

17.5.2. By Method

17.5.3. By End-use

17.5.4. By Application

17.5.5. By Technology

18. Key Countries In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

18.1. Introduction

18.1.1. Market Value Proportion Analysis, By Key Countries

18.1.2. Global Vs. Country Growth Comparison

18.2. US In-vitro Toxicology Testing Market Analysis

18.2.1. Value Proportion Analysis by Market Taxonomy

18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.2.2.1. By Method

18.2.2.2. By End-use

18.2.2.3. By Application

18.2.2.4. By Technology

18.3. Canada In-vitro Toxicology Testing Market Analysis

18.3.1. Value Proportion Analysis by Market Taxonomy

18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.3.2.1. By Method

18.3.2.2. By End-use

18.3.2.3. By Application

18.3.2.4. By Technology

18.4. Mexico In-vitro Toxicology Testing Market Analysis

18.4.1. Value Proportion Analysis by Market Taxonomy

18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.4.2.1. By Method

18.4.2.2. By End-use

18.4.2.3. By Application

18.4.2.4. By Technology

18.5. Brazil In-vitro Toxicology Testing Market Analysis

18.5.1. Value Proportion Analysis by Market Taxonomy

18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.5.2.1. By Method

18.5.2.2. By End-use

18.5.2.3. By Application

18.5.2.4. By Technology

18.6. Germany In-vitro Toxicology Testing Market Analysis

18.6.1. Value Proportion Analysis by Market Taxonomy

18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.6.2.1. By Method

18.6.2.2. By End-use

18.6.2.3. By Application

18.6.2.4. By Technology

18.7. France In-vitro Toxicology Testing Market Analysis

18.7.1. Value Proportion Analysis by Market Taxonomy

18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.7.2.1. By Method

18.7.2.2. By End-use

18.7.2.3. By Application

18.7.2.4. By Technology

18.8. Italy In-vitro Toxicology Testing Market Analysis

18.8.1. Value Proportion Analysis by Market Taxonomy

18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.8.2.1. By Method

18.8.2.2. By End-use

18.8.2.3. By Application

18.8.2.4. By Technology

18.9. BENELUX In-vitro Toxicology Testing Market Analysis

18.9.1. Value Proportion Analysis by Market Taxonomy

18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.9.2.1. By Method

18.9.2.2. By End-use

18.9.2.3. By Application

18.9.2.4. By Technology

18.10. UK In-vitro Toxicology Testing Market Analysis

18.10.1. Value Proportion Analysis by Market Taxonomy

18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.10.2.1. By Method

18.10.2.2. By End-use

18.10.2.3. By Application

18.10.2.4. By Technology

18.11. Nordic Countries In-vitro Toxicology Testing Market Analysis

18.11.1. Value Proportion Analysis by Market Taxonomy

18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.11.2.1. By Method

18.11.2.2. By End-use

18.11.2.3. By Application

18.11.2.4. By Technology

18.12. China In-vitro Toxicology Testing Market Analysis

18.12.1. Value Proportion Analysis by Market Taxonomy

18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.12.2.1. By Method

18.12.2.2. By End-use

18.12.2.3. By Application

18.12.2.4. By Technology

18.13. Japan In-vitro Toxicology Testing Market Analysis

18.13.1. Value Proportion Analysis by Market Taxonomy

18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.13.2.1. By Method

18.13.2.2. By End-use

18.13.2.3. By Application

18.13.2.4. By Technology

18.14. South Korea In-vitro Toxicology Testing Market Analysis

18.14.1. Value Proportion Analysis by Market Taxonomy

18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.14.2.1. By Method

18.14.2.2. By End-use

18.14.2.3. By Application

18.14.2.4. By Technology

18.15. GCC Countries In-vitro Toxicology Testing Market Analysis

18.15.1. Value Proportion Analysis by Market Taxonomy

18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.15.2.1. By Method

18.15.2.2. By End-use

18.15.2.3. By Application

18.15.2.4. By Technology

18.16. South Africa In-vitro Toxicology Testing Market Analysis

18.16.1. Value Proportion Analysis by Market Taxonomy

18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.16.2.1. By Method

18.16.2.2. By End-use

18.16.2.3. By Application

18.16.2.4. By Technology

18.17. Turkey In-vitro Toxicology Testing Market Analysis

18.17.1. Value Proportion Analysis by Market Taxonomy

18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

18.17.2.1. By Method

18.17.2.2. By End-use

18.17.2.3. By Application

18.17.2.4. By Technology

18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Concentration

19.3. Market Share Analysis of Top Players

19.4. Market Presence Analysis

19.4.1. By Regional footprint of Players

19.4.2. Product footprint by Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Benchmarking

20.3. Competition Deep Dive

20.3.1. MERCK KGAA

20.3.1.1. Overview

20.3.1.2. Product Portfolio

20.3.1.3. Sales Footprint

20.3.1.4. Strategy Overview

20.3.2. CHARLES RIVER

20.3.2.1. Overview

20.3.2.2. Product Portfolio

20.3.2.3. Sales Footprint

20.3.2.4. Strategy Overview

20.3.3. BIO-RAD LABORATORIES, INC.

20.3.3.1. Overview

20.3.3.2. Product Portfolio

20.3.3.3. Sales Footprint

20.3.3.4. Strategy Overview

20.3.4. ABBOTT

20.3.4.1. Overview

20.3.4.2. Product Portfolio

20.3.4.3. Sales Footprint

20.3.4.4. Strategy Overview

20.3.5. THERMO FISHER SCIENTIFIC INC.

20.3.5.1. Overview

20.3.5.2. Product Portfolio

20.3.5.3. Sales Footprint

20.3.5.4. Strategy Overview

20.3.6. CATALENT, INC.

20.3.6.1. Overview

20.3.6.2. Product Portfolio

20.3.6.3. Sales Footprint

20.3.6.4. Strategy Overview

20.3.7. GE HEALTHCARE

20.3.7.1. Overview

20.3.7.2. Product Portfolio

20.3.7.3. Sales Footprint

20.3.7.4. Strategy Overview

20.3.8. QUEST DIAGNOSTICS INCORPORATED

20.3.8.1. Overview

20.3.8.2. Product Portfolio

20.3.8.3. Sales Footprint

20.3.8.4. Strategy Overview

20.3.9. EUROFINS SCIENTIFIC

20.3.9.1. Overview

20.3.9.2. Product Portfolio

20.3.9.3. Sales Footprint

20.3.9.4. Strategy Overview

20.3.10. LABORATORY CORPORATION OF AMERICA HOLDINGS

20.3.10.1. Overview

20.3.10.2. Product Portfolio

20.3.10.3. Sales Footprint

20.3.10.4. Strategy Overview

20.3.11. EVOTEC

20.3.11.1. Overview

20.3.11.2. Product Portfolio

20.3.11.3. Sales Footprint

20.3.11.4. Strategy Overview

20.3.12. CREATIVE BIOARRAY

20.3.12.1. Overview

20.3.12.2. Product Portfolio

20.3.12.3. Sales Footprint

20.3.12.4. Strategy Overview

20.3.13. GENTRONIX

20.3.13.1. Overview

20.3.13.2. Product Portfolio

20.3.13.3. Sales Footprint

20.3.13.4. Strategy Overview

20.3.14. BIOIVT

20.3.14.1. Overview

20.3.14.2. Product Portfolio

20.3.14.3. Sales Footprint

20.3.14.4. Strategy Overview

20.3.15. SGS SA

20.3.15.1. Overview

20.3.15.2. Product Portfolio

20.3.15.3. Sales Footprint

20.3.15.4. Strategy Overview

20.3.16. AGILENT TECHNOLOGIES

20.3.16.1. Overview

20.3.16.2. Product Portfolio

20.3.16.3. Sales Footprint

20.3.16.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

Table 1: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 2: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 3: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 4: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 5: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 6: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 7: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 8: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 9: Global In-vitro Toxicology Testing Market, By Region, 2017 – 2021

Table 10: Global In-vitro Toxicology Testing Market, By Region, 2022 – 2032

Table 11: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 12: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 13: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 14: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 15: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 16: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 17: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 18: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 19: North America In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 20: North America In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 21: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 22: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 23: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 24: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 25: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 26: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 27: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 28: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 29: Latin America In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 30: Latin America In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 31: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 32: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 33: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 34: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 35: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 36: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 37: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 38: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 39: Europe In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 40: Europe In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 41: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 42: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 43: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 44: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 45: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 46: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 47: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 48: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 49: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 50: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2022 – 2032

Table 51: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021

Table 52: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032

Table 53: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021

Table 54: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032

Table 55: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021

Table 56: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032

Table 57: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021

Table 58: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032

Table 59: MEA In-vitro Toxicology Testing Market, By Country, 2017 – 2021

Table 60: MEA In-vitro Toxicology Testing Market, By Country, 2022 – 2032